Levonorgestrel Intrauterine System
Cross-source consensus on Levonorgestrel Intrauterine System from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Benefits
Preparation
Comparisons
Where it comes from
Highlighted claims
- The trial used the 52 mg Mirena levonorgestrel intrauterine system. — Cost-effectiveness of levonorgestrel intrauterine system versus hysteroscopic niche resection for caesarean scar–related spotting in China: an economic evaluation alongside a randomised controlled trial
- LNG-IUS insertion in the trial was performed during the non-menstrual phase under ultrasound guidance and without anaesthesia. — Cost-effectiveness of levonorgestrel intrauterine system versus hysteroscopic niche resection for caesarean scar–related spotting in China: an economic evaluation alongside a randomised controlled trial
- The LNG-IUS provides therapeutic hormone release for up to 5 years. — Cost-effectiveness of levonorgestrel intrauterine system versus hysteroscopic niche resection for caesarean scar–related spotting in China: an economic evaluation alongside a randomised controlled trial
- Earlier evidence found LNG-IUS reduced spotting more than expectant management at 6 months. — Cost-effectiveness of levonorgestrel intrauterine system versus hysteroscopic niche resection for caesarean scar–related spotting in China: an economic evaluation alongside a randomised controlled trial
- Earlier cohort evidence found LNG-IUS more effective than HNR for postmenstrual spotting reduction. — Cost-effectiveness of levonorgestrel intrauterine system versus hysteroscopic niche resection for caesarean scar–related spotting in China: an economic evaluation alongside a randomised controlled trial